Correction to: British Journal of Cancer https://doi.org/10.1038/s41416-023-02553-y, published online 30 December 2023
In this article the funding section has been omitted during the production process. It should read:
Funding information
ASC received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No # 860245 (to MV). E.H. was supported by an aspirant FWO fellowship 1106119N. KRK received funding to perform metabolomics mass spectrometry analysis, which was funded by a research grant from FWO (FWO KAN2018 871 1501419N), further experiments were supported by the KNAW early career award 2022 and FEBS excellence award 2022 (to KRK).
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sánchez-Castillo, A., Heylen, E., Hounjet, J. et al. Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer. Br J Cancer 130, 701 (2024). https://doi.org/10.1038/s41416-024-02603-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-024-02603-z
